Cholestatic liver diseases comprise a heterogeneous group of disorders characterized by impaired bile formation or flow, ...

A large meta-analysis, published in Diabetology & Metabolic Syndrome, suggested that semaglutide improved several liver-related and metabolic outcomes in people with or at risk of developing MASH, ...

Familial Hypobetalipoproteinemia (FHBL), caused by variants in the apolipoprotein B (APOB) gene, is a rare autosomal ...

HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced a strategic partnership with Houston Research Institute (HRI). HRI is ...

Organ transplants are a "never-ending tragedy," with referrals steadily going up while the number of organs available remains ...